Malaria Incidence: Clinical Trials

4 trials for Malaria Incidence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 active not recruiting, 1 completed. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Not yet recruiting 2, Active not recruiting 1

Follow Malaria Incidence: new trials by email Literature Review of Malaria Incidence trials Research Report on Malaria Incidence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Permethrin-Treated Baby Wraps for Malaria Prevention in Refugee Settings
Factory-treated lesu, Soaked lesu, Untreated lesu - Malaria (Plasmodium Falciparum), Malaria Incidence
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill13502027-09-012026-10-29
Insecticide-Treated Baby Wraps for the Prevention of Malaria
Permethrin-treated lesu, Etofenprox-treated lesu, Untreated lesu - Malaria (Plasmodium Falciparum), Malaria Incidence
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill12962027-01-012026-08-19
Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition
SQ-LNS, Integrated Nutritional Screening - Malaria Incidence, Seasonal Malaria Chemoprevention
Not applicableActive not recruitingUniversity of California, San Francisco4382025-07-032026-03-06
Malaria Incidence in Infants in Bancoumana, Mali
Malaria Infection, Malaria Incidence
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)6002007-07-242017-07-02

Narrower conditions

Malaria (3)  ·  Malaria, Falciparum (2)  ·  Anemia (1)

Broader conditions

Infections (3)  ·  Mosquito-Borne Diseases (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Vector Borne Diseases (3)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Sponsors

University of North Carolina, Chapel Hill (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  University of California, San Francisco (1)

Countries

Uganda (2)  ·  Burkina Faso (1)  ·  United States (1)

Top investigators

Ross Boyce, MD, MSc (2)  ·  Catherine Oldenburg (1)

NIH funding

R21AI182714 (1)